icotec's CMORE® CT System Gains CMS Approval for Spinal Technology Payment
icotec's CMORE® CT System Receives New Technology Add-On Payment Approval
In a significant advancement in spinal surgery technology, icotec, a pioneer in radiolucent implants, has announced that its innovative CMORE® CT System has received approval for the New Technology Add-On Payment (NTAP) from the Centers for Medicare & Medicaid Services (CMS), effective October 1, 2026. This milestone expands access to icotec's cutting-edge spinal stabilization solutions for eligible Medicare procedures, positioning the company as a leader in providing solutions for spine surgery patients.
What is the CMORE® CT System?
The CMORE® CT System is designed for posterior cervicothoracic stabilization and features icotec's proprietary BlackArmor® technology. It is a non-metallic, radiolucent implant system made entirely from Carbon/PEEK, featuring polyaxial screws and rods that can be customized to accommodate individual patient anatomy. This system is particularly noteworthy as it stands out as the only FDA-approved posterior cervicothoracic system for addressing spinal infections, showcasing icotec's commitment to developing safe and effective medical solutions.
Impact of the CMS Approval
The NTAP approval represents a crucial milestone for icotec, allowing eligible hospitals to receive reimbursement for procedures using the innovative CMORE® CT System. This program offers additional financial support to eligible hospitals that treat Medicare patients with qualifying spinal conditions. According to Christoph Eigenmann, CEO of icotec USA, this recognition by the CMS empowers clinicians to utilize the CMORE® CT System confidently, enhancing their ability to